drugset / Trial / NCT00364468

Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients

NCT00364468

Phase 2 Completed 107 enrolled Kyowa Kirin, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

To assess the duration of severe neutropenia in cycle 1 of chemotherapy after treatment with a single injection of KRN125 or multiple daily injections of filgrastim.

Timeline

Start
2006-03
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Pegfilgrastim Protein / enzyme biologic

Indications